Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 2142603 approvals3 trials

Raphas Co., Ltd.

Official website

KOSDAQ-listed transdermal drug delivery (TDDS) company developing dissolving microneedle patches based on its proprietary DEN technology.

As of 2026-10-10, Raphas Co., Ltd. has 3 Korean MFDS device approvals, 30 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2006 and listed on KOSDAQ in 2019, Raphas is a company specializing in dissolving microneedle patches based on transdermal drug delivery (TDDS) technology. It uses its proprietary DEN (Droplet Extension) technology to manufacture beauty patches and over-the-counter drug patches, while developing prescription drug patches, vaccine patches, and a blood-glucose diagnostic device. Its DEN technology achieves a yield above 90% with monthly production of millions of microneedle patches; it has in-licensed the Mpg tuberculosis vaccine technology from Seoul National University (KRW 300 million upfront, up to KRW 1.2 billion in milestones), co-develops hepatitis B and polio vaccine patches with the Serum Institute, and jointly develops donepezil and other drug patches with Boryung Pharmaceutical (KRW 200 million upfront, up to KRW 800 million in milestones).

Products & technology

  • Beauty microneedle patchHigh-functionality beauty-care microneedle patch
  • OTC drug microneedle patchOTC transdermal drug delivery patch
  • Drug absorption enhancer deviceMedical device to enhance drug absorption
  • Blood-glucose diagnostic deviceDiagnostic device for blood glucose measurement

Regulatory approvals

data.go.kr

3 Korean MFDS device approvals · 2016–2026

  • MFDSAcupuncture needle, reusable2026-04-13
    Product approval · Class 1제신 26-435 호
  • MFDSAcupuncture and moxibustion apparatus2026-01-12
    Product approval · Class 3제허 26-37 호
  • MFDSDepressors for medical use2016-05-12
    Product approval · Class 3제허 16-349 호

Clinical trials

data.go.kr

3 MFDS clinical trial authorisations · 2018–2021 (Phase 1 3)

  • Phase 1DF190012021-10-18

    1 trial site

  • Phase 1Rap180012020-03-18

    2 trial sites

  • Phase 1Rap180012018-10-01

    1 trial site

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

전문의약품 패치 · 연구개발 · R&D on prescription drug microneedle patches

백신 패치(B형간염, 소아마비) · B형간염, 소아마비 · 동물실험 효능 확인 · Joint research with Serum Institute; HBV efficacy confirmed via animal studies in 2017-2018, IPV joint research ongoing since 2018

Mpg 결핵백신 · 결핵 · 제제연구 및 전임상 · In-licensed strain from Seoul National University; commercial culture and animal efficacy evaluation underway

3D 마이크로회절리소그래피 기반 마이크로니들 제조방법 · 제조공정 연구 · Co-owns 50% of patent with Kansas State University; process R&D underway under a Ministry of Trade, Industry and Energy government project

Key disclosures

KRX KIND via OpenDART
Show 2 more events

Publications

PubMed · affiliation-matched
Show 20 more publications

Patents

KIPRIS · applicant-matched
Show 129 more patents

AI reads

MAA server logs · IP-verified
74
Times AI engines pulled Raphas Co., Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

9
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

65
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

16
live 3
Last 7 days
62
live 9
Last 30 days
74
live 9
All time
  • OpenAIChatGPT-Userlive9
  • OpenAIOAI-SearchBot54
  • PerplexityPerplexityBot6
  • GoogleGoogleOther2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Raphas Co., Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

DIO Corporation1 shared

DIO Corporation, established in 1988 and listed on KOSDAQ in 2000, manufactures and sells dental implants.

DongBang Medical Co., Ltd.1 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

MEDYSSEY CO.,LTD1 shared

Manufactures spinal implants and metal 3D-printed patient-specific implants, exporting to over 25 countries.

INTEROJO CO. LTD.100

Interojo, founded 2000 and KOSDAQ-listed 2010, manufactures contact lenses under its Clalen brand domestically and via OEM/ODM overseas.

MITECH CO.,LTD.100

MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.

JETEMA Co.,Ltd.90

Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.

Corentec Co., Ltd.85

Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.

NanoenTek,Inc.85

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

SEJONG MEDICAL Co.Ltd.,85

Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.

REMEDI Inc.85

Founded in 2012 and listed on KOSDAQ in 2026, REMEDI develops portable X-ray imaging devices based on its low-dose, miniaturized X-ray technology.

Laseroptek Co., Ltd.85

KOSDAQ-listed medical device company developing the LOTUS and HELIOS laser aesthetic devices and the PALLAS vitiligo treatment device.

AIOBIO Co., Ltd.85

Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition